Cranial Drill Urgent Recall Alert

Serious safety risks

Urgent Class I Medical Device Recall

Integra LifeSciences has issued an urgent recall of specific Codman Disposable Perforators and Craniotomy Kits due to a serious manufacturing defect that may lead to device disassembly during neurosurgical procedures. The FDA has classified this as a Class I recall, the most serious type, due to the risk of severe injury or death.

Affected Products

  • Codman Disposable Perforator 14 mm – UDI: 10381780513599
  • Codman Craniotomy Kit (includes Perforator, Cranio-blade, Wire Pass Drill) – UDI: 10381780513629

Lot/Serial Numbers: Full List of Affected Lots

Reason for Recall

A faulty ultrasonic weld (known as a “proud weld”) on the device’s outer sleeve may cause the perforator to disassemble unexpectedly during use. In some cases, the device fails to disengage properly, putting patients at serious risk for:

  • Brain tissue injury
  • Bleeding or dural damage
  • Extended surgery time
  • Irreversible harm or even death

To date, 10 serious injuries have been reported—including devices lodged in the skull and fragments difficult to remove. No fatalities have been reported.

Recommended Actions for Users and Facilities

  • Immediately stop using and quarantine all affected products.
  • Review inventory against the provided lot numbers.
  • Notify surgical and supply staff of the recall.
  • Contact Integra for a Return Material Authorization (RMA) and return the product for credit.

Device Function

Codman Disposable Perforators are single-use neurosurgical tools designed to drill precise openings into the skull during craniotomy. They are engineered to disengage automatically after drilling to prevent over-penetration—but this defect undermines that safety feature.

Contact

For questions or to report issues, call Integra LifeSciences at 1-800-654-2873 or email FCA3@integralife.com.

Check the FDA recall web page for updates. The FDA is currently reviewing information about this potentially high-risk device issue and will keep the public informed as significant new information becomes available.

Abbott Safety Alert for Freestyle Libre Systems

Misuse may cause battery overheating and incorrect readings The FDA has issued a safety notification regarding the FreeStyle Libre, FreeStyle Libre 14 day, and FreeStyle Libre 2 Flash Glucose Monitoring Systems. The notification warns users of the potential for...

Camber Recalls Atovaquone Oral Suspension USP

Camber Recalls Atovaquone Oral Suspension USP for Potential Contamination Camber Pharmaceuticals Inc. recently issued a voluntary nationwide recall of Atovaquone Oral Suspension USP due to potential contamination. The recall was announced by the U.S. Food and Drug...

Prodigy Proclaim Spinal Cord Stimulation Systems

Significant advancement for chronic pain treatment On February 15, 2023, the U.S. Food and Drug Administration (FDA) announced the approval of the Prodigy Proclaim and Proclaim XR Spinal Cord Stimulation (SCS) systems. This approval marks a significant step forward in...